Skip to main content
SpringerLink
Log in

PPIs increase risks of hepatic encephalopathy and mortality

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. MELD = Model End Stage Liver Disease

Reference

  • Nardelli S, et al. Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics. Hepatology : [27 pages], 5 Oct 2018. Available from: URL: http://dx.doi.org/10.1002/hep.30304

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PPIs increase risks of hepatic encephalopathy and mortality. Reactions Weekly 1724, 8 (2018). https://doi.org/10.1007/s40278-018-52987-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-52987-6

Search

Navigation